130 related articles for article (PubMed ID: 2298705)
21. Tyramine sulfate excretion may be a better predictor of antidepressant response than monoamine oxidase activity.
Stewart JW; Harrison W; Cooper TB; Quitkin FM
Psychiatry Res; 1988 Aug; 25(2):195-201. PubMed ID: 3051071
[TBL] [Abstract][Full Text] [Related]
22. Toward a biochemical classification of depressive disorders, VI: Platelet MAO activity and clinical symptoms in depressed patients.
Gudeman JE; Schatzberg AF; Samson JA; Orsulak PJ; Cole JO; Schildkraut JJ
Am J Psychiatry; 1982 May; 139(5):630-3. PubMed ID: 7072851
[TBL] [Abstract][Full Text] [Related]
23. Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression.
Davidson J; McLeod MN; Blum MR
Am J Psychiatry; 1978 Apr; 135(4):467-9. PubMed ID: 345825
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients.
Robinson DS; Nies A; Corcella J; Cooper TB; Spencer C; Keefover R
J Clin Psychiatry; 1982 May; 43(5 Pt 2):8-15. PubMed ID: 7042699
[TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacology of phenelzine.
Robinson DS; Nies A; Ravaris CL; Ives JO; Bartlett D
Arch Gen Psychiatry; 1978 May; 35(5):629-35. PubMed ID: 365127
[TBL] [Abstract][Full Text] [Related]
26. The importance of dose in isocarboxazid therapy.
Davidson J; Turnbull C
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):49-52. PubMed ID: 6735995
[TBL] [Abstract][Full Text] [Related]
27. Phenelzine v imipramine in atypical depression. A preliminary report.
Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin J; Tricamo E; Markowitz JS; Klein DF
Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621
[TBL] [Abstract][Full Text] [Related]
28. Open label study of alprazolam in severely depressed inpatients.
Feighner JP
J Clin Psychiatry; 1983 Sep; 44(9):332-4. PubMed ID: 6138346
[TBL] [Abstract][Full Text] [Related]
29. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
Georgotas A; McCue RE; Friedman E; Cooper TB
J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
[TBL] [Abstract][Full Text] [Related]
30. Tranylcypromine: patterns and predictors of response.
White K; White J
J Clin Psychiatry; 1986 Jul; 47(7):380-2. PubMed ID: 3522559
[TBL] [Abstract][Full Text] [Related]
31. Phenelzine for chronic depression: a study of continuation treatment.
Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
[TBL] [Abstract][Full Text] [Related]
32. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
McGrath PJ; Stewart JW; Nunes EN; Quitkin FM
J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
[TBL] [Abstract][Full Text] [Related]
33. Pattern analysis of antidepressant response to fluoxetine.
Fieve RR; Goodnick PJ; Peselow ED; Barouche F; Schlegel A
J Clin Psychiatry; 1986 Nov; 47(11):560-2. PubMed ID: 3533909
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic and side-effect profile of a selective and reversible MAO-A inhibitor, brofaromine. Results of dose-finding trials in depressed patients.
Schiwy W; Heath WR; Delini-Stula A
J Neural Transm Suppl; 1989; 28():33-44. PubMed ID: 2677240
[TBL] [Abstract][Full Text] [Related]
35. Platelet MAO activity and age at onset of depression in elderly depressed women.
Alexopoulos GS; Lieberman KW; Young RC; Shamoian CA
Am J Psychiatry; 1984 Oct; 141(10):1276-8. PubMed ID: 6486267
[TBL] [Abstract][Full Text] [Related]
36. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants.
Chan CH; Janicak PG; Davis JM; Altman E; Andriukaitis S; Hedeker D
J Clin Psychiatry; 1987 May; 48(5):197-200. PubMed ID: 3571174
[TBL] [Abstract][Full Text] [Related]
37. Chronic depression: response to placebo, imipramine, and phenelzine.
Stewart JW; McGrath PJ; Quitkin FM; Rabkin JG; Harrison W; Wager S; Nunes E; Ocepek-Welikson K; Tricamo E
J Clin Psychopharmacol; 1993 Dec; 13(6):391-6. PubMed ID: 8120152
[TBL] [Abstract][Full Text] [Related]
38. Triiodothyronine potentiation of the antidepressant effect of phenelzine.
Joffe RT
J Clin Psychiatry; 1988 Oct; 49(10):409-10. PubMed ID: 3170493
[TBL] [Abstract][Full Text] [Related]
39. Defining the boundaries of atypical depression.
Quitkin FM; Harrison W; Liebowitz M; McGrath P; Rabkin JG; Stewart J; Markowitz J
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):19-21. PubMed ID: 6376482
[TBL] [Abstract][Full Text] [Related]
40. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
